Mobile BSL labs are portable biosafety laboratories built into vans, trailers, or containers. They allow scientists to safely study and diagnose infectious diseases directly in outbreak zones or remote areas, without needing to transport samples long distances.
BSL‑4: Highly dangerous pathogens with no known cure (e.g., Ebola).
In India, Mobile BSL‑3 laboratories (biosafety labs on wheels) are introduced and operated mainly by the Indian Council of Medical Research (ICMR) under the Ministry of Health and Family Welfare (MoHFW). Their functioning is controlled by the Department of Health Research (DHR) and coordinated through national schemes like the Pradhan Mantri–Ayushman Bharat Health Infrastructure Mission (PM‑ABHIM).
Current Status in India:
First deployed mobile BSL‑3 labs during the Nipah virus outbreak in Kerala (2023). These labs are called RAMBAAN (Rapid Action Mobile Biosafety and Analytical Laboratory). 44 BSL‑3 labs (including 4 mobile units) and 4 BSL‑4 labs sanctioned under central schemes. ICMR is procuring two more mobile BSL‑3 labs to expand outbreak response capacity.
When we have traditional labs working in large areas and facilities, why do you think we need mobile laboratories?
Mobile BSL laboratories fill a critical gap that traditional stationary labs simply cannot address. During outbreaks, time is the biggest determinant of survival, and transporting samples over long distances delays diagnosis, increases risk of sample contamination, and limits rapid containment. Mobile BSL-3 units bring high-level biosafety infrastructure directly to the outbreak zone allowing on-site testing, faster surveillance, and immediate isolation measures. They are especially vital for remote, tribal, border, and disaster affected areas where lab access is poor. Mobile labs also prevent infected samples from traveling through multiple checkpoints, reducing biohazard risks. In short, they offer agility, speed, safety, and reach, qualities essential for modern epidemic preparedness.